BallerAlert on MSN17h
Say Goodbye to Shots! FDA Approves First Self-Administered Flu Vaccine Nasal Spray
The Food and Drug Administration (FDA) has greenlit the first-ever self-administered flu vaccine, FluMist. The agency made the announcement on Friday, explaining that FluMist is a convenient nasal ...
WAPT18h
FDA approves first flu vaccine that can be self-administered at home
FluMist is a nasal spray manufactured by AstraZeneca that has been used to protect against influenza in the United States ...
WSGW1d
FDA approves first self-administered flu vaccine spray
The Food and Drug Administration announced Friday it had broadened the approval of the FluMist nasal spray to become the first “self-administered” influenza vaccine — though a delay in the change ...
Astrazeneca (AZN) Suffers a Larger Drop Than the General Market: Key Insights
The most recent trading session ended with Astrazeneca (AZN) standing at $78.38, reflecting a -0.66% shift from the previouse trading day's closing. The stock's change was less than the S&P 500's ...
STAT1d
FDA approves first at-home flu vaccine in U.S., a nasal spray
FluMist is the only flu vaccine administered by nasal spray, not injection. It is licensed for individuals between the ages ...
FDA approves first self-administered flu vaccine
The vaccine FluMist, manufactured by MedImmune, which was acquired by AstraZeneca in 2007, was first approved by the FDA in ...
Nasal Flu Vaccine Is Approved for At-Home Use
The F.D.A. authorized AstraZeneca’s treatment to be given outside a health care setting, although it will still need a ...
US FDA approves AstraZeneca's self-administered nasal spray flu vaccine
The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's nasal spray flu vaccine for ...
AstraZeneca: Fasenra Approved By FDA To Treat Eosinophilic Granulomatosis With Polyangiitis
AstraZeneca PLC (AZN, AZN.L) announced Wednesday that its Fasenra (benralizumab) has been approved in the US for the treatment of ...
FiercePharma8d
ESMO: AstraZeneca stands by Truqap despite surprise breast cancer flop
As if a limited initial FDA approval was not bad enough, AstraZeneca’s Truqap has recorded a pivotal trial flop that could ...
A gun safety paradox: Study finds some precautions linked to riskier storage practices
Rutgers Health researchers have found that parents who actively teach their children how to handle or shoot firearms are more ...